Details
Description
These reports contain evaluations of the association between dabigatran and various outcomes, with warfarin as the comparison. The outcomes of interest include intracranial hemorrhage, gastrointestinal hemorrhage, ischemic stroke, and acute myocardial infarction. The reports display data on individuals 21 years of age and older and on individuals 65 years of age and older. Additionally, each dabigatran and outcome pair was assessed with a 183-day washout period and a 365-day washout period. See the specific deliverables for what is contained in each report. These queries were distributed to Data Partners in July 2015, and they contain data between November 1, 2010 through December 31, 2013 from the Mini-Sentinel Distribtued Database.
Deliverables (16)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Intracranial Hemorrhage among Individuals 21 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Gastrointestinal Hemorrhage among Individuals 21 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Ischemic Stroke among Individuals 21 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Acute Myocardial Infarction among Individuals 21 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Intracranial Hemorrhage among Individuals 65 Years of Age and Older(183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Gastrointestinal Hemorrhage among Individuals 65 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Ischemic Stroke among Individuals 65 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Acute Myocardial Infarction among Individuals 65 Years of Age and Older (183-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Intracranial Hemorrhage among Individuals 21 Years of Age and Older (365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Gastrointestinal Hemorrhage among Individuals 21 Years of Age and Older (365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Ischemic Stroke among Individuals 21 Years of Age and Older (365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Acute Myocardial Infarction among Individuals 21 Years of Age and Older (365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Intracranial Hemorrhage among Individuals 65 Years of Age and Older(365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Gastrointestinal Hemorrhage among Individuals 65 Years of Age and Older (365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Ischemic Stroke among Individuals 65 Years of Age and Older (365-Day Washout)
Mini-Sentinel Modular Program Report: Use of Dabigatran and Acute Myocardial Infarction among Individuals 65 Years of Age and Older (365-Day Washout)